
CDMO News
Charles River Laboratories and FibroBiologics Sign Letter of Intent for Drug Manufacturing
FibroBiologics Inc. and Charles River Laboratories have announced a significant step in their collaboration, signing a letter of intent that paves the way for enhanced drug development and manufacturing capabilities. FibroBiologics Inc., a clinical-stage biotechnology company specializing in therapies using